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  Protein	   A	   Agarose	   packed	   in	   	   a	   10	   X	   20cm	   column	   :	   Comparable	   HETP,	  
asymmetry	  and	  pressure	  drop	  was	  observed	  	  following	  gamma	  irradiaSon	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The	  intensificaSon	  of	  cell	  culture	  producSon	  and	  conSnuous	  downstream	  processing	  are	  two	  important	  features	  of	  many	  
new	  biomanufacturing	  schemes.	  AddiSonally,	  perfusion	  of	  cell	  culture	  bioreactors	  using	  an	  alternaSng	  tangenSal	  flow	  
(ATF)	  device	  can	  increase	  viable	  cell	  density	  5-­‐10	  fold	  and	  can	  be	  used	  to	  conSnuously	  harvest	  product	  suitable	  for	  
immediate	  downstream	  processing.	  This	  ATF	  process	  is	  used	  in	  current	  commercial	  processes.	  More	  recently,	  perfusion	  
has	  been	  applied	  to	  high	  density	  cell	  banking	  (Tao	  2011	  Biotechnol.Prog.,	  27:	  824–829)	  and	  preparaSon	  of	  N-­‐1	  cell	  
inoculum	  (Yang	  2014	  Biotechnol.	  Prog.,	  30:616–625)	  to	  greatly	  accelerate	  producSon	  turnover	  in	  fed	  batch	  processes.	  
The	  capture	  of	  a	  conSnuous	  process	  feedstream	  is	  facilitated	  by	  use	  of	  prepacked	  columns	  of	  uniform	  performance.	  
Process	  intensificaSon	  may	  include	  rapid	  load	  using	  low	  aspect	  raSo	  columns.	  To	  maintain	  an	  asepSc	  environment	  we	  
are	  developing	  gamma	  irradiated	  proteinA	  affinity	  media	  that	  can	  operate	  for	  long	  periods	  with	  low	  bioburden.	  Together	  
these	  tools	  of	  perfusion	  and	  asepSc	  capture	  can	  facilitate	  the	  engineering	  of	  a	  more	  producSve	  manufacturing	  process.	  
Tools	  for	  intensifica/on	  of	  cell	  culture	  produc/on	  and	  con/nuous	  downstream	  processing	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  Produc(on	  Fed-­‐Batch	  (MAb	  Titer)	  
Upstream:	  ATF	  Perfusion	  Technology	  to	  Intensify	  Fed	  Batch	  
  An	  industrially	  relevant	  mammalian	  CHO	  DP12	  cell	  line	  (ATCC#	  CRL-­‐12445™)	  was	  selected	  to	  evaluate	  the	  seed	  train	  process	  using	  an	  ATF-­‐2	  perfusion	  system	  
with	  0.2	  µm	  hollow	  fiber	  microfilter	  (Repligen).	  CHO	  DP12	  cells	  were	  adapted	  in	  house	  to	  grow	  as	  suspension	  culture	  in	  CD	  OpSCHO	  medium	  supplemented	  
with	  100ng/mL	  LONG®R3IGF-­‐1,	  and	  4mM	  Glutamax.	  This	  cell	  line	  is	  reported	  to	  express	  recombinant	  human	  anS-­‐IL-­‐8.	  
  High	   density	   cryo-­‐bags	   (Charter	  Medical)	   were	   prepared	   by	   filling	   desired	   volume	   of	   condiSoned	  medium	   at	   cell	   density	   of	   100E6	   cells/mL.	   CondiSoned	  
medium	  contains	  5%	  DMSO	  and	  0.11%	   (w/v)	   carboxymethylcellulose	   (Sigma#	  C4888)	  as	   cryo-­‐protectants.	   The	  filled	   cryo-­‐bags	  were	   then	  placed	   in	   freezer	  
cassemes	  (Custom	  Biogenics	  Systems)	  and	  the	  resultant	  cassemes	  were	  posiSoned	  in	  racks.	  Prior	  to	  storing	  them	  in	  liquid	  nitrogen,	  these	  racks	  were	  kept	  in	  
-­‐80°C	  freezer	  for	  24	  hours.	  
  1.5L	  glass	  bioreactors	  (Applikon)	  equipped	  with	  an	  ATF-­‐2	  perfusion	  system	  (Repligen)	  were	  used	  to	  generate	  100E6	  cells/mL	  VCD	  and	  also	  to	  mimic	  the	  n–	  1	  
seed-­‐train	  stage	  (200-­‐L	  bioreactor)	  as	  menSoned	  in	  the	  figure.1.5L	  bioreactor	  	  was	  used	  to	  mimic	  2,000L	  producSon	  fed-­‐batch	  bioreactor	  in	  the	  figure.	  	  
	  Produc(on	  Fed-­‐Batch	  (VCD	  and	  Viability)	  
  ProducSon	  Fed-­‐Batches:	  Cells	  were	  inoculated	  directly	  from	  the	  above	  n-­‐1	  
perfusion	  bioreactor	  at	  0.5E6	  and	  10E6	  cells/mL	  seeding	  densiSes.	  
  Comparable	   Ster	   was	   observed	   at	   high	   seeding	   density	   prod	   fed-­‐batch	  
bioreactor,	  in	  shorter	  Sme.	  Cell	  specific	  producSvity	  was	  unchanged	  






































HD_1L	  Cryo	  bag	  
HD_100mL	  Cryo	  bag	  
  The	  recovery	  and	  growth	  curve	  profiles	  are	  similar	  between	  100mL	  cryo-­‐
bag	  thaw	  compared	  to	  1L	  cryo-­‐bag	  thaw.	  	  
Ø  Perfusion	  with	  ATF	  can	  eliminate	  many	  steps	  in	  seed	  train	  and	  accelerate	  fed	  batch	  produc/on	  






High	  density	  cell	  culture	  
to	  maximize	  seed	  train	  
and	  producSon/Liter	  
High	  efficiency	  capture	  




removes	  steps	  and	  
process	  variability	  
























•  Robust,	  reproducible	  
separaSon	  
•  GMP	  ready	  
documentaSon	  
•  Scalable	  from	  5-­‐60	  
cm	  diameter	  
Downstream:	  pre-­‐packed	  columns	  for	  asep/c	  chromatography	  	  
OPUS	  
Performance	  at	  low	  bed	  height	  
Diameter	  (cm) 10 20 30
Bed	  Height	  (cm) 5 10 5 10 5 10
HETP	  (N/m) 3847 2258 3313 2580 2489 3100
Asymmetry 1.28 1.43 1.4 1.2 1.24 1.21
Separa/on	  performance	  at	  low	  aspect	  ra/o	  
OPUS	  materials	  stable	  to	  25	  KGy	  Gamma	  radia/on	  
Ø Tensile	  strength	  and	  elasScity	  unchanged	  
Ø Pressure	  tolerance	  >	  5	  bar	  
Ø No	  bioburden	  for	  60	  d	  of	  operaSons	  
OPUS	  columns	  suitable	  for	  	  con/nuous	  an/body	  harvest	  
Pre-­‐Gamma	   Post-­‐Gamma	  
HETP	  (N/m)	   3055	   2935	  
Asymmetry	   1.25	   1.4	  
Procedures	  to	  preserve	  performance	  of	  an/body	  
affinity	  agarose	  resin	  
Ø  Protectant	  addiSve	  to	  column	  buffer	  idenSfied	  
Ø  Low	  leaching	  
Ø  Stable	  to	  mulScycle	  use	  
Ø Minimal	  loss	  of	  resin	  capacity	  
Ø  Prepacked	  columns	  can	  perform	  efficiently	  in	  low	  aspect	  ra/o	  mul/-­‐column	  formats	  
Ø  Prepacked	  prA	  chromatography	  media	  can	  be	  prepared	  gamma	  irradiated	  and	  maintain	  
column	  and	  resin	  performance	  


















Pre-­‐Gamma	   30	  kGy+Protectant	   30	  kGy	  in	  Water	  
	   %	  Yield	   Log	  HCP	  Log	  DNA	   Residual	  ProA	  
Pre-­‐	  
Gamma	   100%	   2.9	   3.7	   1.2	  
30kGy	  -­‐	  
Gamma	   97%	   2.6	   3.6	   3.0	  
